Bozhao Li

987 total citations · 1 hit paper
20 papers, 719 citations indexed

About

Bozhao Li is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Bozhao Li has authored 20 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Bozhao Li's work include Cancer Immunotherapy and Biomarkers (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Extracellular vesicles in disease (3 papers). Bozhao Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Extracellular vesicles in disease (3 papers). Bozhao Li collaborates with scholars based in China, United States and Australia. Bozhao Li's co-authors include Guangjun Nie, Suping Li, Zefang Lu, Yinlong Zhang, Feilong Qi, Junchao Xu, Tianjiao Chu, Jiaqi Xu, Guangna Liu and Jingyan Wei and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Bozhao Li

17 papers receiving 718 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The dynamic role of platelets in cancer progression and their therapeutic implications

2023 86 citations Suping Li, Zefang Lu et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bozhao Li China	11	337	271	216	141	105	20	719
Zefang Lu China	8	313 0.9×	229 0.8×	204 0.9×	121 0.9×	86 0.8×	13	635
Claudia Gottstein Germany	16	149 0.4×	354 1.3×	206 1.0×	150 1.1×	198 1.9×	27	856
Huaqin Zuo China	9	280 0.8×	192 0.7×	152 0.7×	77 0.5×	73 0.7×	14	481
Yixin Zhong China	17	632 1.9×	210 0.8×	242 1.1×	37 0.3×	94 0.9×	21	858
Yulin Zhao United States	9	257 0.8×	215 0.8×	127 0.6×	96 0.7×	64 0.6×	20	542
Oscar A. Marcos‐Contreras United States	16	117 0.3×	329 1.2×	174 0.8×	42 0.3×	87 0.8×	30	763
Eva C. Woenne Germany	11	390 1.2×	247 0.9×	225 1.0×	73 0.5×	39 0.4×	12	783
In San Kim South Korea	12	114 0.3×	273 1.0×	98 0.5×	148 1.0×	106 1.0×	22	646
Maureen Aliru United States	10	192 0.6×	206 0.8×	121 0.6×	125 0.9×	67 0.6×	20	693

Countries citing papers authored by Bozhao Li

Since Specialization

Citations

This map shows the geographic impact of Bozhao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bozhao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bozhao Li more than expected).

Fields of papers citing papers by Bozhao Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bozhao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bozhao Li. The network helps show where Bozhao Li may publish in the future.

Co-authorship network of co-authors of Bozhao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bozhao Li. A scholar is included among the top collaborators of Bozhao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bozhao Li. Bozhao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Zhouliang, Zefang Lu, Feilong Qi, et al.. (2025). Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy. Cell Reports Medicine. 6(3). 101984–101984.

Zhang, Yongpeng, Bozhao Li, Xuan Liu, et al.. (2025). DNA computing function switching by programming base stacking interactions with minimal molecular architecture changes. Nature Communications. 16(1). 9369–9369.

Yue, Peng, Min Yu, Bozhao Li, et al.. (2025). Advances in nanocarrier-mediated cancer therapy: Progress in immunotherapy, chemotherapy, and radiotherapy. Chinese Medical Journal. 138(16). 1927–1944.

Zhang, Xiuping, Bozhao Li, Zefang Lu, et al.. (2023). Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus. Nano Today. 49. 101787–101787. 6 indexed citations

Li, Bozhao, Fei Zhu, Zefang Lu, et al.. (2023). Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer. Cancer Research. 83(17). 2924–2937. 11 indexed citations

Chu, Tianjiao, Peina Wang, Bozhao Li, et al.. (2023). Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy. Bioconjugate Chemistry. 34(10). 1894–1901. 8 indexed citations

Wang, Zhaoyang, et al.. (2023). A fractional derivative model for nuclides transport in heterogeneous fractured media. Journal of Contaminant Hydrology. 259. 104265–104265. 2 indexed citations

Li, Suping, Zefang Lu, Tianjiao Chu, et al.. (2023). The dynamic role of platelets in cancer progression and their therapeutic implications. Nature reviews. Cancer. 24(1). 72–87. 86 indexed citations breakdown →

Li, Bozhao, Zefang Lu, Zhenlin Yang, et al.. (2023). Monitoring circulating platelet activity to predict cancer-associated thrombosis. Cell Reports Methods. 3(7). 100513–100513. 6 indexed citations

10.

Li, Bozhao, Xiuping Zhang, Zhouliang Wu, et al.. (2022). Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug. Advanced Science. 9(20). e2200477–e2200477. 34 indexed citations

11.

Wu, Zhouliang, Feilong Qi, Bozhao Li, et al.. (2022). Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy. Nano Today. 48. 101705–101705. 3 indexed citations

12.

Li, Bozhao, et al.. (2021). Protective Effects and Mechanisms of Recombinant Human Glutathione Peroxidase 4 on Isoproterenol‐Induced Myocardial Ischemia Injury. Oxidative Medicine and Cellular Longevity. 2021(1). 6632813–6632813. 12 indexed citations

13.

Wang, Yanwei, et al.. (2021). Improvement of stability and in vivo antioxidant effect of human glutathione peroxidase mutant by PEGylation. International Journal of Pharmaceutics. 609. 121152–121152. 4 indexed citations

14.

Li, Bozhao, Tianjiao Chu, Jingyan Wei, et al.. (2021). Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment. Nano Letters. 21(6). 2588–2595. 125 indexed citations

15.

Li, Bozhao, Jingyan Wei, Chunzhi Di, et al.. (2020). Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction. Acta Pharmaceutica Sinica B. 11(7). 2059–2069. 18 indexed citations

16.

Qi, Feilong, Meifang Wang, Bozhao Li, et al.. (2020). Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells. Acta Pharmacologica Sinica. 41(7). 895–901. 30 indexed citations

17.

Li, Suping, Yinlong Zhang, Shih‐Hsin Ho, et al.. (2020). Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles. Nature Biomedical Engineering. 4(7). 732–742. 124 indexed citations

18.

Xu, Junchao, Yinlong Zhang, Jiaqi Xu, et al.. (2019). Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models. Advanced Materials. 32(4). e1905145–e1905145. 192 indexed citations

19.

Zhang, Yinlong, Shih‐Hsin Ho, Bozhao Li, Guangjun Nie, & Suping Li. (2019). Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment. Medicinal Research Reviews. 40(3). 1084–1102. 31 indexed citations

20.

Yang, Dan, Hui Yue, Bozhao Li, et al.. (2017). The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis. Clinical & Experimental Immunology. 189(1). 120–126. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact